Chamber and committees

As announced in our Programme for Government, we are investing £10 billion in health infrastructure over the next decade, to renew and replace health facilities across Scotland. The Scottish Government provide NHS Boards with over £140 million of capital funding each to invest in maintaining their existing estate and replacing and upgrading equipment. Over the next five years, as detailed in the Infrastructure Investment Plan published in February 2021, we will double our annual funding for maintenance, so that in total £1 billion will be invested in enhancing or refurbishing existing facilities, and updating and modernising key equipment.

The Scottish Government have asked NHS Lothian to submit a Full Business Case for the new Eye Pavilion following our approval of their Outline Business Case. It is for NHS Lothian to manage their local budget and determine where their maintenance budget is directed, but we would expect them to maintain a safe and compliant facility, until the new eye hospital opens.

The following table presents the information requested.

Table 1 : Number of readmissions with a diagnosis of deep-vein thrombosis readmitted within 90 days of discharge following an orthopaedic or any type of surgery.

The following table presents the information requested.

Table 1 : Number of people that died within 90 days of discharge following an orthopaedic or any type of surgery, with pulmonary embolism and deep-vein thrombosis among the causes of death.

NHS Scotland are working with colleagues in some international countries to create a system that will enable them to collect the appropriate information. A range of mechanisms is currently under consideration for how this can be done most effectively and efficiently.

This information is not held centrally .

This information requested is not currently available.

With the British Heart Foundation Data Science centre, the University of Edinburgh is looking at the long-term risk of deep vein thrombosis and pulmonary embolism after infection with COVID-19. Analyses are currently ongoing, but results are anticipated soon.

This work is funded by the British Heart Foundation and the Stroke Association, with support from Health Data Research UK.

The Scottish Government is not funding research specifically investigating links between long-COVID and deep vein thrombosis (DVT). However, both direct research funding and research support funding has been provided to projects that are investigating the longer term effects of COVID-19.

On December 22 2020, the Chief Scientist Office announced the outcome of its funding call for Scottish-led research on the long-term effects of COVID-19 infection. Following a competitive independently peer reviewed process 9 long-COVID research projects were funded with a total funding commitment of around £2.5 million. Details of the funded projects are available from the Chief Scientist Office website.

Long Covid Call – Chief Scientist Office (scot.nhs.uk)

Scottish Government were advised of Mr Alexander’s death by NHS Ayrshire & Arran on 16 February 2021. At that time, the Board also confirmed that a review was ongoing to determine Reporting of Injuries, Diseases and Dangerous Occurrence Regulations (RIDDOR) reportable status. They further advised that the Health and Safety Executive had been advised by telephone of the death of a member of staff and that NHS Ayrshire & Arran would submit a RIDDOR notification if the internal review indicated this requirement.

Scottish Government has since been advised that in accordance with Health and Safety Executive COVID-19 RIDDOR guidance, Mr Alexander’s death was not, and has not, been formally reported to the Health and Safety Executive as it did not meet the requirements for reporting under RIDDOR.

Scottish Ambulance Service staffing is up 63.5% under this Government, by 2,346.1 WTE between Sept 2006 and June 2021, and now stands at 6,040.4 WTE.

In terms of specific numbers of paramedics in post since 2017, this is detailed in the following table:

The cervical screening programme routinely invites anyone with a cervix who is between the ages of 25 and 64 for a test every 5 years. This is in line with the recommendation given by the UK National Screening Committee (UK NSC), to change the primary screening test from cytology (looking at cervical cells through a microscope to find those which could develop into cancer) to testing for high-risk human papillomavirus (HPV). The new test is more effective at identifying those at risk of developing cervical cancer, meaning those who don’t have HPV will be invited for a cervical screening test every five years instead of every three. The Scottish Government, along with the rest of the UK, is advised on all aspects of cervical screening including the move to HPV testing by the UK NSC.

Further information on the UK NSC’s recommendation can found on the following website: https://view-health-screening-recommendations.service.gov.uk/cervical-cancer/.